Single-cell GWAS — Cell-Type-Specific Genetic Association Analysis
Also known as: sc-GWAS, single-cell GWAS integration, cell-type-specific GWAS, single-cell genetic association analysis
Single-cell GWAS is an integrative bioinformatics pipeline that maps genome-wide association study (GWAS) signals onto single-cell transcriptomic landscapes to identify which cell types and individual cells carry disproportionate genetic risk for a disease or trait. By leveraging single-cell RNA-seq atlases alongside GWAS summary statistics, it moves beyond tissue-level associations to reveal the precise cellular contexts in which disease-associated genetic variants exert their effects.
Key highlights
- Directly connects population-level genetic risk signals to cell-type resolution, enabling mechanistic hypotheses about disease biology.
- Leverages existing public GWAS summary statistics — no new genotyping of single cells is required.
- Robust permutation-based testing frameworks (e.g., scDRS) control for technical confounders such as cell size and expression noise.
- Applicable across many disease areas where both GWAS and single-cell atlases are publicly available.
- Can identify rare or transitional cell states enriched for disease risk that would be invisible in bulk RNA-seq analyses.
Intuition
This section is available to Pro members. Upgrade to Pro
How it works
This section is available to Pro members. Upgrade to Pro
When to use it
Use single-cell GWAS when you have a well-powered GWAS for a trait or disease and want to identify the specific cell types or cellular states that mediate genetic risk — particularly for complex traits such as neuropsychiatric disorders, autoimmune diseases, or metabolic conditions where bulk-tissue analyses obscure cell-type heterogeneity. A high-quality, annotated scRNA-seq atlas of the relevant tissue is required. Do not use this approach when GWAS summary statistics are underpowered (n < ~10,000 effective cases) or when a high-quality cell atlas for the target tissue does not exist, as results will be unreliable. It is also not appropriate for identifying causal variants directly — it identifies enriched cell types, not causal mechanisms, and must be followed by functional validation.
Strengths & limitations
- Directly connects population-level genetic risk signals to cell-type resolution, enabling mechanistic hypotheses about disease biology.
- Leverages existing public GWAS summary statistics — no new genotyping of single cells is required.
- Robust permutation-based testing frameworks (e.g., scDRS) control for technical confounders such as cell size and expression noise.
- Applicable across many disease areas where both GWAS and single-cell atlases are publicly available.
- Can identify rare or transitional cell states enriched for disease risk that would be invisible in bulk RNA-seq analyses.
- Results depend critically on GWAS power — underpowered studies produce noisy gene scores that yield false or missing cell-type associations.
- Cell-type annotations in the scRNA-seq reference must be accurate and sufficiently granular; coarse annotations miss biologically meaningful distinctions.
- The pipeline identifies enriched cell types but does not identify causal variants, genes, or regulatory mechanisms directly.
- Cross-tissue or cross-species transfer of GWAS signals to a single-cell atlas introduces biological and technical mismatches.
- Computational burden is substantial for large atlases (millions of cells) and requires bioinformatics infrastructure.
Common pitfalls
This section is available to Pro members. Upgrade to Pro
Applications
This section is available to Pro members. Upgrade to Pro
Frequently asked
Do I need to have genotype data from the same individuals as the scRNA-seq data?
No. The most common implementation uses published GWAS summary statistics from a separate large cohort, which are then projected onto any scRNA-seq dataset from the relevant tissue. Having matched genotype and single-cell data from the same individuals enables sc-eQTL analysis, which is a related but distinct and more powerful approach when such data are available.
What is the difference between single-cell GWAS and sc-eQTL analysis?
Single-cell GWAS projects GWAS summary statistics onto scRNA-seq data to identify enriched cell types — it does not test genetic variant-expression associations directly. Sc-eQTL analysis requires matched genotype and scRNA-seq data from the same individuals and tests whether specific genetic variants regulate gene expression in specific cell types. Both are complementary: single-cell GWAS identifies which cell types are relevant; sc-eQTL identifies the specific genetic regulatory mechanisms operating in those cells.
Which tools are most commonly used for single-cell GWAS?
scDRS (single-cell disease relevance score) is among the most widely adopted tools for projecting GWAS risk onto individual cells. MAGMA or LD-score regression are typically used to compute gene-level scores from GWAS summary statistics as an upstream step. Seurat or Scanpy are used for scRNA-seq preprocessing and cell-type annotation. The analysis pipeline thus combines tools from both the genomics and single-cell communities.
How large does the scRNA-seq dataset need to be?
There is no strict minimum, but power to detect cell-type enrichment increases with the number of cells per cell type. Studies typically use tens of thousands to millions of cells from well-annotated atlases. For rare cell types (less than 1% of cells), very large datasets are needed to achieve sufficient power, as small cluster sizes reduce statistical sensitivity even when the biological signal is real.
Can single-cell GWAS be applied to non-human organisms?
Yes, though this requires a GWAS in the target organism (or careful cross-species gene ortholog mapping if projecting human GWAS onto mouse or other model organism single-cell data). Cross-species analyses add uncertainty due to evolutionary divergence in gene regulation, so results should be interpreted cautiously and validated in the target organism.
Sources
- 1.Zhang, M. J., Hou, K., Dey, K. K., Sakaue, S., Jagadeesh, K. A., Weinand, K., ... & Price, A. L. (2022). Polygenic enrichment distinguishes disease associations of individual cells in single-cell RNA-seq data. Nature Genetics, 54(8), 1224-1234.
- 2.Bryois, J., Calini, D., Macnair, W., Foo, L., Urich, E., Ortmann, W., ... & De Jager, P. L. (2022). Cell-type-specific cis-eQTLs in eight human brain cell types identify novel risk genes for psychiatric and neurological disorders. Nature Neuroscience, 25(8), 1104-1112.
You have read it. What now?
Cite this page
ScholarGate. (2026, June 3). Single-cell GWAS. ScholarGate. https://scholargate.app/bioinformatics/single-cell-gwas